NexgenRx Inc.
NEGXF
$0.33
$0.0622.04%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 140.48% | -558.38% | 291.41% | 996.57% | 7.43% |
| Total Depreciation and Amortization | -74.45% | 110.46% | 0.18% | -0.89% | -7.48% |
| Total Amortization of Deferred Charges | -- | -78.87% | -- | -- | -- |
| Total Other Non-Cash Items | -33.33% | 1.40% | 66.96% | -172.33% | -26.76% |
| Change in Net Operating Assets | -199.58% | 404.50% | 97.62% | -41.63% | 65.53% |
| Cash from Operations | -81.60% | 410.21% | 594.35% | 0.94% | 162.92% |
| Capital Expenditure | 94.94% | 100.00% | 51.79% | -729.78% | -72.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.49% | 100.63% | 40.16% | 6.62% | -37.50% |
| Cash from Investing | 27.03% | 118.44% | 41.11% | -136.00% | -48.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 26.18% | 55.48% | -8.68% | -41.08% | -64.25% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.04% | -7.70% | -1,065.70% | 0.85% | 6.12% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.49% | -3.69% | -13,877.27% | -1.50% | -188.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.06% | 1,714.30% | 1,052.14% | -47.41% | 134.61% |